A potential coronavirus vaccine is showing promising early results in test subjects

A potential vaccine for the novel coronavirus is showing promising early results, according to its manufacturer.

Developed by Moderna, Inc., the vaccine — formally known as mRNA-1273 — is “generally safe and well-tolerated” and has shown few side effects in its test subjects, with the exception of headaches, redness, and fever, none of which lasted more than 24 hours, per the results.

The study was led by the National Institute of Allergy and Infectious Diseases and included 45 volunteers, all of whom were given different doses of the medication to see if it is safe and whether or not it could induce antibodies to COVID-19, which it did.

After being given the green light by the Food and Drug Administration, Moderna plans to enlist the help of hundreds of volunteers so it can begin the next step in its months-long testing process, which will last through the summer and will ultimately reveal whether or not the vaccine can actually prevent someone from contracting coronavirus.